Skip to content

Clinical trials

Completed Metabolic Diseases trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Status: Completed Country / region: Mexico Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20092
20102
20141
20151
20161
20181
20201
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Eli Lilly and Company5
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Ionis Pharmaceuticals, Inc.1
Takeda1
Ultragenyx Pharmaceutical Inc1
University of Guadalajara1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases17
Diabetes Mellitus, Type 211
Glucose Metabolism Disorders10
Diabetes Mellitus9
Endocrine System Diseases9
Lipid Metabolism Disorders3
Dyslipidemias2
Hyperlipidemias2
Hypertriglyceridemia2
Lysosomal Storage Diseases2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.